A comparison of the antimicrobial activity of meropenem and selected broad-spectrum antimicrobials tested against multi-drug resistant Gram-negative bacilli including bacteraemic Salmonella spp.: Initial studies for the MYSTIC programme in India

International Journal of Antimicrobial Agents

Volumn 20, Issue 6, 2002, Pages 426-431

  Jones, Ronald N ^a   Rhomberg, Paul R ^a   Varnam, David J ^a   Mathai, Dilip ^b  

^a JMI LABORATORIES   (United States)

^b CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Carbapenems; ESBL; India; Meropenem; Mystic; Resistance

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEFTIZOXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN; MEROPENEM; MONOBACTAM DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TAZOBACTAM; TOBRAMYCIN; BETA LACTAMASE; THIENAMYCIN DERIVATIVE;

ACINETOBACTER; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS PUTIDA; SALMONELLA; CLASSIFICATION; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; HUMAN; INDIA; METABOLISM;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; HUMANS; INDIA; SALMONELLA; THIENAMYCINS;

EID: 0036890711     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(02)00210-8     Document Type: Article

References (28)

1. Forward K.R., Willey B.M., Low D.E., et al. Molecular mechanisms of cefoxitin resistance in Escherichia coli from the Toronto area hospitals. Diagn. Microbiol. Infect. Dis. 41:2001;57-63.
2. Livermore D.M. Of Pseudomonas, porins, pumps and carbapenems. J. Antimicrob. Chemother. 47:2001;247-250.
3. Livermore D.M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin. Infect. Dis. 34:2002;634-640.
4. Pitout J.D., Sanders C.C., Sanders W.E. Jr. Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli. Am. J. Med. 103:1997;51-59.
5. Towner KJ. Clinical importance and antibiotic resistance of Acinetobacter spp. Proceedings of a symposium held on 4-5 November 1996 at Eilat, Israel, J Med Microbiol 1997;46:721-746.
6. Vanhoof R., Nyssen H.J., Van Bossuyt E., Hannecart-Pokorni E. Aminoglycoside resistance in Gram-negative blood isolates from various hospitals in Belgium and the Grand Duchy of Luxembourg. J. Antimicrob. Chemother. 44:1999;483-488.
7. Knothe H., Shah P., Krcmery V., Antal M., Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection. 11:1983;315-317.
8. Jacoby G.A. Extended-spectrum β-lactamases and other enzymes providing resistance to oxyimino-β-lactams. Infect. Dis. Clin. North Am. 11:1997;875-887.
9. Winokur P.L., Canton R., Casellas J.M., Legakis N. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin. Infect. Dis. 32:(Suppl. 2):2001;S94-S103.
10. Goossens H. MYSTIC program: summary of European data from 1997 to 2000. Diagn. Microbiol. Infect. Dis. 41:2001;183-189.
11. Aggarwal P., Singh M. Studies on antibiotic resistance and serotypes of Escherichia coli isolated from persons without diarrhea in Delhi. Indian J. Med. Sci. 41:1987;163-167.
12. Gaur A., Ramteke P.W., Pathak S.P., Bhattacherjee J.W. Transferable antibiotic resistance among thermotolerant coliforms from rural drinking water in India. Epidemiol. Infect. 109:1992;113-120.
13. Ghosh A.R., Koley H.De.D., Paul M., Nair G.B., Sen D. Enterotoxigenic Escherichia coli associated diarrhoea among infants aged less than six months in Calcutta, India. Eur. J. Epidemiol. 12:1996;81-84.
14. Ghosh A.R., Nair G.B., Naik T.N., et al. Serovars of multi-antibiotic resistant Escherichia coli from the freshwater environs of Calcutta. Indian J. Microbiol. Immunol. 35:1991;273-287.
15. Nandivada L.S., Amyes S.G. Plasmid-mediated beta-lactam resistance in pathogenic gram-negative bacteria isolated in south India. J. Antimicrob. Chemother. 26:1990;279-290.
16. Raghunath V., Banker D.D. Study of bacterial pathogens causing diarrhoeal disease in Bombay with special reference to their antibiotic sensitivity pattern. Indian J. Med. Sci. 46:1992;46-51.
17. Ramteke P.W., Gaur A., Pathak S.P., Bhattacharjee J.W. Antibiotic resistance of coliforms in drinking water in rural areas. Indian J. Med. Res. 91:1990;185-188.
18. Singh M., Chaudhry M.A., Yadava J.N., Sanyal S.C. The spectrum of antibiotic resistance in human and veterinary isolates of Escherichia coli collected from 1984-86 in northern India. J. Antimicrob. Chemother. 29:1992;159-168.
19. Vila J., Vargas M., Ruiz J., et al. Susceptibility patterns of enteroaggregative Escherichia coli associated with traveller's diarrhoea: emergence of quinolone resistance. J. Med. Microbiol. 50:2001;996-1000.
20. Jones RN, India Antimicrobial Resistance Study Group, Mathai D, Biedenbach DJ. Evaluation of 6 broad-spectrum beta-lactams tested against recent clinical isolates from India: A 10 medical center survey. In Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 2001. Abstract C2-290. Washington, DC: American Society for Microbiology. p. 116.
21. Turner P.J., Greenhalgh J.M., Edwards J.R., McKellar J. The MYSTIC (meropenem yearly susceptibility test information collection) programme. Int. J. Antimicrob. Agents. 13:1999;117-125.
22. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically-Fifth Edition: Approved standard M7-A5. NCCLS, 2000. Wayne, PA.
23. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; Twelfth informational supplement. M100-S12. NCCLS, 2002. Wayne, PA.
24. Abigail S., Mathai E., Jesudason M.V., John T.J. Ceftazidime resistance among Klebsiella pneumoniae in south India. Indian J. Med. Res. 102:1995;53-55.
25. Peter J.B. Antimicrobial resistance in India and the United States. Clin. Infect. Dis. 23:1996;1315-1316.
26. Arya S.C. Emerging antibiotic resistance in Indian communities. Clin. Infect. Dis. 25:1997;944-945.
27. Jones R.N. Summation: β-lactam resistance surveillance in the Asia-Western Pacific region. Diagn. Microbiol. Infect. Dis. 35:1999;333-338.
28. Jones R.N., Masterton R. Determining the value of antimicrobial surveillance programs. Diagn. Microbiol. Infect. Dis. 41:2001;171-175.